Enact Holdings, Inc.
US ˙ NasdaqGS ˙ US29249E1091

Introduction

This page provides a comprehensive analysis of the known insider trading history of James H Bloem. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate James H Bloem has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:GENNQ / Genesis Healthcare, Inc. Director 428,610
US:ACT / Enact Holdings, Inc. Director 11,163
US:HUM / Humana Inc. Sr. VP, CFO & Treasurer 0
Director 0
Director 180,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by James H Bloem. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ACT / Enact Holdings, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACT / Enact Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACT / Enact Holdings, Inc. Insider Trades
Insider Sales ACT / Enact Holdings, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACT / Enact Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACT / Enact Holdings, Inc. Insider Trades
Insider Purchases GENNQ / Genesis Healthcare, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACT / Enact Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GENNQ / Genesis Healthcare, Inc. Insider Trades
Insider Sales GENNQ / Genesis Healthcare, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACT / Enact Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GENNQ / Genesis Healthcare, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by James H Bloem as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2020-06-03 2020-06-03 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 124,079 428,610 40.74
2019-06-05 2019-06-05 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 124,079 304,531 68.76
2018-06-06 2018-06-06 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 68,650 180,452 61.40
2017-06-08 2017-06-07 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 52,000 111,802 86.95
2017-05-05 2017-05-04 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1,223 11,163 12.30 245.25 299,941 2,737,726
2017-05-05 2017-05-03 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -668 9,940 -6.30 243.76 -162,832 2,422,974
2016-08-09 2016-08-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 201 10,608 1.93 248.31 49,910 2,634,072
2016-06-09 2016-06-08 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 40,000 59,802 202.00
2016-05-09 2016-05-05 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 1,188 10,407 12.89 210.34 249,884 2,189,008
2015-06-30 2015-06-05 4/A AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 826 9,219 9.84 302.30 249,700 2,786,904
2015-06-30 2015-06-04 4/A AGN Allergan plc
Ordinary Shares, par value $0.0001
F - Taxes -549 8,393 -6.14 303.38 -166,556 2,546,268
2015-06-08 2015-06-05 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 826 9,219 9.84 302.30 249,700 2,786,904
2015-06-08 2015-06-04 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
F - Taxes -549 8,393 -6.14 303.38 -166,556 2,546,268
2015-06-05 2015-06-03 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 19,802 19,802
2014-05-13 2014-05-09 4 ACT Actavis plc
Ordinary Shares, par value $0.0001
A - Award 1,142 8,942 14.64 197.05 225,031 1,762,021
2013-11-08 2013-11-07 4 HUM HUMANA INC
Restricted Stock Units
M - Exercise -17,201 0 -100.00 0.17 -2,867
2013-11-08 2013-11-07 4 HUM HUMANA INC
Humana Common
F - Taxes -8,642 30,326 -22.18 96.00 -829,675 2,911,448
2013-11-08 2013-11-07 4 HUM HUMANA INC
Humana Common
M - Exercise 17,201 38,968 79.02 0.17 2,867 6,496
2013-10-03 2013-10-01 4 ACT Actavis plc
Ordinary Shares
A - Award 7,800 7,800
2013-10-01 2013-10-01 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
D - Sale to Issuer -24,176 0 -100.00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer -14,680 0 -100.00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer -28,660 0 -100.00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer -10,100 0 -100.00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
D - Sale to Issuer -9,640 0 -100.00
2013-10-01 2013-09-30 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
D - Sale to Issuer -4,170 24,176 -14.71
2013-08-07 2013-08-07 4 HUM HUMANA INC
Humana Common
S - Sale -33,000 21,767 -60.26 91.79 -3,029,232 1,998,100
2013-08-05 2013-08-05 4 HUM HUMANA INC
Options
M - Exercise -46,436 0 -100.00
2013-08-05 2013-08-02 4 HUM HUMANA INC
Humana Common
F - Taxes -41,066 54,767 -42.85 90.46 -3,715,036 4,954,497
2013-08-05 2013-08-02 4 HUM HUMANA INC
Humana Common
M - Exercise 46,436 95,833 94.01 69.48 3,226,141 6,657,998
2013-05-29 2013-05-28 4 HUM HUMANA INC
Options
M - Exercise -7,589 7,589 -50.00 61.18 -464,295 464,295
2013-05-29 2013-05-28 4 HUM HUMANA INC
Options
M - Exercise -9,963 0 -100.00 46.40 -462,283
2013-05-29 2013-05-28 4 HUM HUMANA INC
Humana Common
F - Taxes -13,880 49,397 -21.94 80.16 -1,112,621 3,959,664
2013-05-29 2013-05-28 4 HUM HUMANA INC
Humana Common
M - Exercise 7,589 63,277 13.63 61.18 464,295 3,871,287
2013-05-29 2013-05-28 4 HUM HUMANA INC
Humana Common
M - Exercise 9,963 55,688 21.79 46.40 462,283 2,583,923
2013-05-09 2013-05-07 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares par value $0.01 per share
A - Award 14,680 14,680
2013-05-09 2013-05-07 4 WCRX Warner Chilcott plc
Ordinary shares, par value $0.01 per share
A - Award 4,170 28,346 17.25
2013-03-20 2013-03-20 4 HUM HUMANA INC
Options
M - Exercise -2,155 9,963 -17.78 46.40 -99,992 462,283
2013-03-20 2013-03-20 4 HUM HUMANA INC
Humana Common
M - Exercise 2,155 45,725 4.95 46.40 99,992 2,121,640
2013-02-22 2013-02-20 4 HUM HUMANA INC
Restricted Stock Units
A - Award 6,006 6,006
2013-02-22 2013-02-20 4 HUM HUMANA INC
Options
A - Award 18,201 18,201
2012-09-18 2012-09-14 4 WCRX Warner Chilcott plc
Option to purchase ordinary shares, par value $0.01
A - Award 28,660 28,660
2012-06-28 2012-06-26 4 ROHI ROTECH HEALTHCARE INC
Common Stock, $.0001 par value
A - Award 4,000 180,000 2.27
2012-03-29 2012-03-29 4 HUM HUMANA INC
Options
M - Exercise -35,005 0 -100.00 62.10 -2,173,810
2012-03-29 2012-03-29 4 HUM HUMANA INC
Humana Common
S - Sale -35,005 43,570 -44.55 90.27 -3,159,793 3,932,929
2012-03-29 2012-03-29 4 HUM HUMANA INC
Humana Common
M - Exercise 35,005 78,575 80.34 62.10 2,173,810 4,879,508
2012-03-23 2012-03-21 4 HUM HUMANA INC
Options
M - Exercise -7,589 15,178 -33.33 61.18 -464,295 928,590
2012-03-23 2012-03-21 4 HUM HUMANA INC
Options
M - Exercise -12,117 12,118 -50.00 46.40 -562,229 562,275
2012-03-23 2012-03-21 4 HUM HUMANA INC
Options
M - Exercise -22,576 0 -100.00 41.83 -944,354
2012-03-23 2012-03-21 4 HUM HUMANA INC
Options
M - Exercise -1,439 46,436 -3.01 69.48 -99,975 3,226,141
2012-03-23 2012-03-21 4 HUM HUMANA INC
Options
M - Exercise -8,800 35,005 -20.09 62.10 -546,480 2,173,810
2012-03-23 2012-03-21 4 HUM HUMANA INC
Humana Common
F - Taxes -8,951 43,570 -17.04 85.50 -765,355 3,725,453
2012-03-23 2012-03-21 4 HUM HUMANA INC
Humana Common
F - Taxes -28,271 52,521 -34.99 85.50 -2,417,312 4,490,808
2012-03-23 2012-03-21 4 HUM HUMANA INC
Humana Common
M - Exercise 7,589 80,792 10.37 61.18 464,295 4,942,855
2012-03-23 2012-03-21 4 HUM HUMANA INC
Humana Common
M - Exercise 12,117 73,203 19.84 46.40 562,229 3,396,619
2012-03-23 2012-03-21 4 HUM HUMANA INC
Humana Common
M - Exercise 8,800 61,086 16.83 62.10 546,480 3,793,441
2012-03-23 2012-03-21 4 HUM HUMANA INC
Humana Common
M - Exercise 22,576 52,286 75.99 41.83 944,354 2,187,123
2012-03-23 2012-03-21 4 HUM HUMANA INC
Humana Common
M - Exercise 1,439 29,710 5.09 69.48 99,975 2,064,102
2012-02-27 2012-02-23 4 HUM HUMANA INC
Restricted Stock Units
A - Award 5,528 5,528 0.17 922 922
2012-02-27 2012-02-23 4 HUM HUMANA INC
Options
A - Award 28,436 28,436 88.65 2,520,780 2,520,780
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)